Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
[Imidazoline receptor agonists: are they actual today?].
Nebieridze, D V; Kamyshova, T V.
Kardiologiia ; 52(12): 90-3, 2012.
Article in Russian | MEDLINE | ID: mdl-23237448

Subject(s)
Antihypertensive Agents/therapeutic use , Blood Pressure/physiology , Hypertension/drug therapy , Imidazoline Receptors/agonists , Sympathetic Nervous System/drug effects , Blood Pressure/drug effects , Humans , Hypertension/physiopathology , Sympathetic Nervous System/physiopathology
2.
Impaired antiatherogenic function of high-density lipoproteins in the presence of various risk factors for coronary heart disease.
Serdyuk, A P; Ozerova, I N; Kamyshova, T V; Perova, N V; Metel'skaya, V A.
Bull Exp Biol Med ; 139(3): 290-2, 2005 Mar.
Article in English, Russian | MEDLINE | ID: mdl-16027833

ABSTRACT

We studied acception of cholesterol from Fu5AH hepatoma cells by blood serum from subjects with normal level of high-density lipoprotein cholesterol and hyperlipidemia (alone or in combination with other risk factors for coronary heart disease). Cholesterol-binding activity of high-density lipoproteins decreased in subjects with hyperlipidemia alone or in combination with excess body weight and/or arterial hypertension. Impairment of high-density lipoprotein activity was associated with changes in their phospholipid composition.


Subject(s)
Cholesterol, HDL/metabolism , Coronary Disease/etiology , Coronary Disease/prevention & control , Adult , Blood Pressure , Body Mass Index , Body Weight , Carcinoma, Hepatocellular/metabolism , Cholesterol/blood , Cholesterol/metabolism , Cholesterol, HDL/blood , Coronary Disease/blood , Humans , Hyperlipidemias/complications , Liver Neoplasms/metabolism , Male , Middle Aged , Risk Factors , Tumor Cells, Cultured , Urban Population
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL